ASAM Practice Pearls - Understanding Medetomidine: Emerging Challenges for Addiction Medicine

5 (5 votes)

  • Register
    • Non-Member - Free!
    • Regular Member - Free!
    • Retired - Free!
    • Early Career Physician - Free!
    • Resident - Free!
    • Student - Free!
    • Associate - Free!
    • ASAM Staff - Free!
    • International Member - Free!
    • Emeritus Member - Free!
    • Provisional Member - Free!
    • Fellow Member - Free!
    • Honorary Member - Free!
    • CRT Member - Free!

Understanding Medetomidine: Emerging Challenges for Addiction Medicine

Published: Monday, February 9, 2026
Podcast Series

Overview

Join ASAM Practice Pearls for in-depth discussions on addiction prevention, treatment, and recovery. Listen to interviews with leading experts as they delve into critical topics and share practical tools you can use to improve patient care and promote public health. Each Episodes offers actionable key takeaways that providers can immediately apply in their practice and providing additional resources for continued learning.

The target audience for these comprehensive level episodes includes all medication prescribers and care team members.

This session addresses the following ACGME Competencies: Patient Care and Procedural Skills, Practice-based Learning and Improvement, and Medical Knowledge.

Learning Objectives

These are the learning objectives for season 2. Not all learning objectives will be covered in every episode. 

  1. Explain emerging evidence and clinical considerations for different substances to enhance assessment and support safe, effective treatment planning for individuals with substance use disorders. 
  2. Apply up-to-date, evidence-based, and patient-centered strategies and guidance to enhance patient engagement, promote safety, and improve outcomes for individuals with substance use disorders across various healthcare settings. 
  3. Recognize how structural, social, and cultural factors influence substance use, treatment access, and patient–clinician interactions, and implement strategies to enhance equity and deliver culturally responsive, inclusive addiction care. 

Disclaimer

This podcast is for informational purposes only and should not be considered health advice.

  • We are not responsible for any losses, damages, or liabilities that may arise from the use of this podcast.
  • This podcast is not intended to replace professional medical advice.
  • The views expressed in this podcast may not be those of the host or the management.

Registration Rates

ASAM Learner TypeRate
ASAM Member$0
Non-Member$0
Associate Member$0
Resident Member*$0
Student Member*$0

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Open: 02/09/2026 - 02/09/2029

Close Access Date: 02/09/2029 

Instructions

  1. Click on the Contents tab to begin this activity.
  2. Listen to the podcast and review the show notes.
  3. Click Acknowledgement, then the button Read Terms to attest that you have listened to the podcast episode in its entirety and have reviewed the show notes.
  4. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
  5. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Stephen Taylor

MD, MPH, DFAPA, DFASAM

Pathway Healthcare

Stephen M. Taylor, MD, MPH, DFAPA, DFASAM is the Chief Medical Officer of Pathway Healthcare, a company that operates 13 outpatient mental health and addiction treatment offices across Alabama, Mississippi, Tennessee, and Texas. Dr. Taylor is board-certified in psychiatry, child and adolescent psychiatry, addiction psychiatry, and addiction medicine. Dr. Taylor is in his 15th season as the Medical Director of the Player Assistance/Anti-Drug Program of the National Basketball Association (NBA) and the National Basketball Players Association (NBPA).
Dr. Taylor is a Distinguished Fellow of the American Psychiatric Association, and a Distinguished Fellow of the American Society of Addiction Medicine (DFASAM). He is Vice Chair of ASAM’s Legislative Advocacy Committee and serves on ASAM’s Public Policy Committee. He is co-chair of ASAM’s Writing Subcommittee on Advancing Racial Justice, which drafted ASAM’s Public Policy Statement on Advancing Racial Justice in Addiction Medicine. He also chairs ASAM’s Delegation to the AMA House of Delegates and is a member of the ASAM Board of Directors.
Dr. Taylor is a certified Medical Review Officer (MRO) and serves on the Board of Directors of the Medical Review Officer Certification Council (MROCC). He also serves on the Drug Testing Advisory Board (DTAB) of the Center for Substance Abuse Prevention of the Substance Abuse and Mental Health Services Administration (SAMHSA), and he serves on the Board of Directors of the Addiction Prevention Coalition, a non-profit community organization in Birmingham, AL.
An honors graduate of Harvard College, with a Master of Public Health degree from the Harvard School of Public Health and a medical degree from Howard University College of Medicine, Dr. Taylor completed “Triple Board” residency in pediatrics, psychiatry, and child and adolescent psychiatry at the Albert Einstein College of Medicine/Bronx Municipal Hospital Center, then completed a fellowship in addiction psychiatry at NYU School of Medicine/Bellevue Hospital Center.

No Financial Disclosures.

Dr. Jeanmarie Perrone, MD

Professor of Emergency Medicine and Medical Toxicology, Perelman School of Medicine at the University of Pennsylvania

Jeanmarie Perrone, MD is a Professor in the Department of Emergency Medicine, the Director of the Division of Medical Toxicology and the founding Director of the Center for Addiction Medicine and Policy at the University of Pennsylvania.  Dr. Perrone has led numerous investigations and initiatives in opioid stewardship and ED treatment of Opioid Use Disorder (OUD) with buprenorphine.  She serves on several regional and national task forces and advisory committees with the State of Pennsylvania, the CDC and FDA addressing judicious opioid use and MOUD treatment access. She has advocated at the state and national level for harm reduction and ED treatment for OUD and is a  co-investigator in a 30 site NIDA sponsored trial of ED buprenorphine.  Dr. Perrone has been featured in prominent news media including the New York Times, USA Today and National Public Radio and published in the New England Journal of Medicine and JAMA . She has won numerous awards for education and mentorship of students, residents and fellows and is boarded in emergency medicine, medical toxicology and addiction medicine.  

No Financial Disclosures.

Michael Lynch, MD FACEP FACMT

Senior Medical Director

University of Pittsburgh School of Medicine - Division of Medical Toxicology, Department of Emergency Medicine

No Financial Disclosures.

Accreditation & Credits

Joint Accreditation Statement
image

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available
  • Physicians: .5 Credit
  • Nurses & NPs: .5 Nursing Contact Hour
  • PAs: .5 Credit
  • Interprofessional Continuing Education: .5 Credit
  • Certified Counselors: NBCC Contact Hours not offered image 
    American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
  • NAADAC: CE Credits not offered
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is not designated for MOC/CCP points.

Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

The complete list of disclosures and designation statements are linked below.

Key:

Complete
Failed
Available
Locked
Understanding Medetomidine: Emerging Challenges for Addiction Medicine
Recorded 02/09/2026  |  21 minutes
Recorded 02/09/2026  |  21 minutes This 21-minute podcast episode was released on Monday, February 9, 2026. Access the episode on your favorite streaming service or listen here.
Show notes
Open to download resource.
Open to download resource.
Medetomidine Factsheet
Open to download resource.
Open to download resource. This factsheet equips providers with essential information to recognize and treat medetomidine withdrawal syndrome. Developed January 2026.
Episode Evaluation
5 Questions
5 Questions Scroll down on evaluation, there may be questions that expand past the size of the window.
Acknowledgement
Agree to terms to continue.
Agree to terms to continue. I attest that I have listened to this podcast episode in its entirety and have reviewed the show notes and accompanying resources.
Claim Credits & Certificate
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available Attendees should claim only the credit commensurate with the extent of their participation in the activity.